{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:52:35Z","timestamp":1781556755975,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s12028-023-01896-x","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T19:02:00Z","timestamp":1703876520000},"page":"91-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Therapeutic Interventions on Cerebral Autoregulatory Function Following Severe Traumatic Brain Injury: A Secondary Analysis of the BOOST-II Study"],"prefix":"10.1007","volume":"41","author":[{"given":"Ayush","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Begunova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelynne","family":"Olexa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Beekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido J.","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Matouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Ortega-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy R.","family":"Temkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Diaz-Arrastia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"de Havenon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9711-3340","authenticated-orcid":false,"given":"Nils H.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"1896_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11940-018-0501-x","volume":"20","author":"A Wang","year":"2018","unstructured":"Wang A, Ortega-Gutierrez S, Petersen NH. Autoregulation in the neuro ICU. Curr Treat Option Ne. 2018;20:20.","journal-title":"Curr Treat Option Ne"},{"issue":"Suppl 2","key":"1896_CR2","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1007\/s12028-014-0046-0","volume":"21","author":"M Czosnyka","year":"2014","unstructured":"Czosnyka M, Miller C. Monitoring P in the IMCC on M. Monitoring of cerebral autoregulation. Neurocrit Care. 2014;21(Suppl 2):S95-102.","journal-title":"Neurocrit Care"},{"issue":"Suppl 2","key":"1896_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s12028-014-0041-5","volume":"21","author":"PL Roux","year":"2014","unstructured":"Roux PL, Menon DK, Citerio G, Vespa P, Bader MK, Brophy GM, et al. Consensus summary statement of the international multidisciplinary consensus conference on multimodality monitoring in neurocritical care: a statement for healthcare professionals from the neurocritical care society and the European society of intensive care medicine. Neurocrit Care. 2014;21(Suppl 2):S1-26.","journal-title":"Neurocrit Care"},{"key":"1896_CR4","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1097\/CCM.0b013e3182514eb6","volume":"40","author":"MJH Aries","year":"2012","unstructured":"Aries MJH, Czosnyka M, Budohoski KP, Steiner LA, Lavinio A, Kolias AG, et al. Continuous determination of optimal cerebral perfusion pressure in traumatic brain injury. Crit Care Med. 2012;40:2456\u201363.","journal-title":"Crit Care Med"},{"key":"1896_CR5","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1097\/CCM.0000000000002575","volume":"45","author":"J Donnelly","year":"2017","unstructured":"Donnelly J, Czosnyka M, Adams H, Robba C, Steiner LA, Cardim D, et al. Individualizing thresholds of cerebral perfusion pressure using estimated limits of autoregulation. Crit Care Med. 2017;45:1464\u201371.","journal-title":"Crit Care Med"},{"key":"1896_CR6","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1097\/CCM.0000000000002619","volume":"45","author":"DO Okonkwo","year":"2017","unstructured":"Okonkwo DO, Shutter LA, Moore C, Temkin NR, Puccio AM, Madden CJ, et al. Brain oxygen optimization in severe traumatic brain injury phase-II. Crit Care Med. 2017;45:1907\u201314.","journal-title":"Crit Care Med"},{"key":"1896_CR7","doi-asserted-by":"publisher","first-page":"e030727","DOI":"10.1136\/bmjopen-2019-030727","volume":"9","author":"E Beqiri","year":"2019","unstructured":"Beqiri E, Smielewski P, Robba C, Czosnyka M, Cabeleira MT, Tas J, et al. Feasibility of individualised severe traumatic brain injury management using an automated assessment of optimal cerebral perfusion pressure: the COGiTATE phase II study protocol. BMJ Open. 2019;9:e030727.","journal-title":"BMJ Open"},{"key":"1896_CR8","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1089\/neu.2017.5003","volume":"34","author":"X Liu","year":"2017","unstructured":"Liu X, Maurits NM, Aries MJH, Czosnyka M, Ercole A, Donnelly J, et al. Monitoring of optimal cerebral perfusion pressure in traumatic brain injured patients using a multi-window weighting algorithm. J Neurotraum. 2017;34:3081\u20138.","journal-title":"J Neurotraum"},{"key":"1896_CR9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3171\/2014.3.JNS131500","volume":"120","author":"B Depreitere","year":"2014","unstructured":"Depreitere B, G\u00fciza F, den Berghe GV, Schuhmann MU, Maier G, Piper I, et al. Pressure autoregulation monitoring and cerebral perfusion pressure target recommendation in patients with severe traumatic brain injury based on minute-by-minute monitoring data. J Neurosurg. 2014;120:1451\u20137.","journal-title":"J Neurosurg"},{"key":"1896_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/HTR.0b013e3181d27fe3","volume":"25","author":"E Bagiella","year":"2010","unstructured":"Bagiella E, Novack TA, Ansel B, Diaz-Arrastia R, Dikmen S, Hart T, et al. Measuring outcome in traumatic brain injury treatment trials. J Head Trauma Rehab. 2010;25:375\u201382.","journal-title":"J Head Trauma Rehab"},{"key":"1896_CR11","doi-asserted-by":"publisher","first-page":"R670","DOI":"10.1186\/cc3822","volume":"9","author":"AJ Mar\u00edn-Caballos","year":"2005","unstructured":"Mar\u00edn-Caballos AJ, Murillo-Cabezas F, Cayuela-Dom\u00ednguez A, Dom\u00ednguez-Rold\u00e1n JM, Rinc\u00f3n-Ferrari MD, Valencia-Anguita J, et al. Cerebral perfusion pressure and risk of brain hypoxia in severe head injury: a prospective observational study. Crit Care. 2005;9:R670.","journal-title":"Crit Care"},{"key":"1896_CR12","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1161\/STROKEAHA.110.596874","volume":"42","author":"JM Schmidt","year":"2011","unstructured":"Schmidt JM, Ko S-B, Helbok R, Kurtz P, Stuart RM, Presciutti M, et al. Cerebral perfusion pressure thresholds for brain tissue hypoxia and metabolic crisis after poor-grade subarachnoid hemorrhage. Stroke. 2011;42:1351\u20136.","journal-title":"Stroke"},{"key":"1896_CR13","doi-asserted-by":"crossref","unstructured":"Megjhani M, Weiss M, Ford J, Terilli K, Kastenholz N, Nametz D, et al. Optimal cerebral perfusion pressure and brain tissue oxygen in aneurysmal subarachnoid hemorrhage. Stroke. 2022.","DOI":"10.1161\/STROKEAHA.122.040339"},{"key":"1896_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/CCM.0b013e318192fbd7","volume":"37","author":"JJJ Chang","year":"2009","unstructured":"Chang JJJ, Youn TS, Benson D, Mattick H, Andrade N, Harper CR, et al. Physiologic and functional outcome correlates of brain tissue hypoxia in traumatic brain injury. Crit Care Med. 2009;37:283\u201390.","journal-title":"Crit Care Med"},{"key":"1896_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","volume":"80","author":"N Carney","year":"2017","unstructured":"Carney N, Totten AM, O\u2019Reilly C, Ullman JS, Hawryluk GWJ, Bell MJ, et al. Guidelines for the management of severe traumatic brain injury fourth edition. Neurosurgery. 2017;80:6\u201315.","journal-title":"Neurosurgery"},{"key":"1896_CR16","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00134-019-05900-x","volume":"46","author":"R Chesnut","year":"2020","unstructured":"Chesnut R, Aguilera S, Buki A, Bulger E, Citerio G, Cooper DJ, et al. A management algorithm for adult patients with both brain oxygen and intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC). Intensive Care Med. 2020;46:919\u201329.","journal-title":"Intensive Care Med"},{"key":"1896_CR17","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s00134-019-05805-9","volume":"45","author":"GWJ Hawryluk","year":"2019","unstructured":"Hawryluk GWJ, Aguilera S, Buki A, Bulger E, Citerio G, Cooper DJ, et al. A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC). Intensive Care Med. 2019;45:1783\u201394.","journal-title":"Intensive Care Med"},{"key":"1896_CR18","doi-asserted-by":"publisher","first-page":"e996","DOI":"10.1097\/CCM.0000000000001816","volume":"44","author":"MJH Aries","year":"2016","unstructured":"Aries MJH, Wesselink R, Elting JWJ, Donnelly J, Czosnyka M, Ercole A, et al. Enhanced visualization of optimal cerebral perfusion pressure over time to support clinical decision making. Crit Care Med. 2016;44:e996\u20139.","journal-title":"Crit Care Med"},{"key":"1896_CR19","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1161\/STROKEAHA.119.026282","volume":"50","author":"A Silverman","year":"2019","unstructured":"Silverman A, Kodali S, Strander S, Gilmore EJ, Kimmel A, Wang A, et al. Deviation from personalized blood pressure targets is associated with worse outcome after subarachnoid hemorrhage. Stroke. 2019;50:2729\u201337.","journal-title":"Stroke"},{"key":"1896_CR20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/STROKEAHA.119.026596","volume":"51","author":"NH Petersen","year":"2020","unstructured":"Petersen NH, Silverman A, Strander SM, Kodali S, Wang A, Sansing LH, et al. Fixed compared with autoregulation-oriented blood pressure thresholds after mechanical thrombectomy for ischemic stroke. Stroke. 2020;51:914\u201321.","journal-title":"Stroke"},{"key":"1896_CR21","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1089\/neu.2021.0197","volume":"38","author":"J Tas","year":"2021","unstructured":"Tas J, Beqiri E, van Kaam RC, Czosnyka M, Donnelly J, Haeren RH, et al. Targeting autoregulation-guided cerebral perfusion pressure after traumatic brain injury (COGiTATE): a feasibility randomized controlled clinical trial. J Neurotraum. 2021;38:2790\u2013800.","journal-title":"J Neurotraum"},{"key":"1896_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s12028-011-9630-8","volume":"16","author":"E Sorrentino","year":"2012","unstructured":"Sorrentino E, Diedler J, Kasprowicz M, Budohoski KP, Haubrich C, Smielewski P, et al. Critical thresholds for cerebrovascular reactivity after traumatic brain injury. Neurocrit Care. 2012;16:258\u201366.","journal-title":"Neurocrit Care"},{"key":"1896_CR23","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s00701-017-3310-1","volume":"159","author":"M Czosnyka","year":"2017","unstructured":"Czosnyka M, Czosnyka Z, Smielewski P. Pressure reactivity index: journey through the past 20 years. Acta Neurochir. 2017;159:2063\u20135.","journal-title":"Acta Neurochir"},{"key":"1896_CR24","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1097\/01.CCM.0000218413.51546.9E","volume":"34","author":"M Jaeger","year":"2006","unstructured":"Jaeger M, Schuhmann MU, Soehle M, Meixensberger J. Continuous assessment of cerebrovascular autoregulation after traumatic brain injury using brain tissue oxygen pressure reactivity&ast. Crit Care Med. 2006;34:1783\u20138.","journal-title":"Crit Care Med"},{"key":"1896_CR25","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1161\/STROKEAHA.121.037184","volume":"53","author":"B Owen","year":"2022","unstructured":"Owen B, Vangala A, Fritch C, Alsarah AA, Jones T, Davis H, et al. Cerebral autoregulation correlation with outcomes and spreading depolarization in aneurysmal subarachnoid hemorrhage. Stroke. 2022;53:1975\u201383.","journal-title":"Stroke"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-023-01896-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-023-01896-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-023-01896-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T12:15:29Z","timestamp":1724415329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-023-01896-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1896"],"URL":"https:\/\/doi.org\/10.1007\/s12028-023-01896-x","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]},"assertion":[{"value":"1 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NHP is supported by the National Institutes of Health - National Institute of Neurological Disorders and Stroke (NIH-NINDS) (K23NS110980) and has received clinical research funding from Liminal Sciences. ADH is supported by NIH-NINDS (K23NS105924), has received investigator-initiated clinical research funding from the AAN, has received consultant fees from Integra and Novo Nordisk, has equity in TitinKM and Certus, and receives author fees from UpToDate. EJG is supported by NIH-NINDS (R01NS117904) and receives consulting fees from UCB. SOG is supported by NIH-NINDS (R01NS127114, R03NS1202228), industry investigator-initiated grants from Stryker Neurovascular, Medtronic, Microvention, Methinks, and VizAi, and Society of Vascular and Interventional Neurology, and consulting fees from Medtronic, Stryker, and Microvention. CCM is supported by NIH-NINDS R21NS119992, receives consulting fees from Microvention-Terumo and Stryker, and speaker fees from Penumbra and Silk Road Medical. NRT and JB are supported by NIH-NINDS (U01NS099084).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase II trial was approved by the local institutional review board at each participating center, and proxy informed consent was obtained from each study participant. This secondary analysis was performed on deidentified data obtained from the Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase II investigators under a data use agreement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\/Informed Consent"}}]}}